Ortona L, Laghi V, Cauda R, Nervo P
Clin Exp Immunol. 1980 Dec;42(3):436-40.
A serial prospective study of cell-mediated immunity to rabbit liver-specific lipoprotein (RLSP) has been done in 26 patients with acute viral hepatitis (AH) (18 HBsAg+ and eight HBsAg-) using a lymphocyte transformation test. An increased stimulation index was recorded in 56% of HBsAg+ cases and in 63% of the HBsAg- group at the first determination within 2 weeks of presentation. A progressive return to normal values was observed during the course of the disease. In one patient, however, the stimulation index remained high at 6 months after presentation and liver biopsy showed the appearance of chronic active hepatitis. Results within the normal range of values were observed when a macromolecular kidney protein fraction was used as antigen: further evidence of an organ-specific component in RLSP preparation to which the immune response seems to be directed. These findings demonstrate the existence of a common and time-limited sensitization to RLSP in acute viral hepatitis irrespective of HBsAg status. It is suggested that RLSP may be a useful alternative to human LSP in evaluating immune reactions in liver diseases.
我们对26例急性病毒性肝炎(AH)患者(18例HBsAg阳性和8例HBsAg阴性)进行了一项关于细胞介导的对兔肝特异性脂蛋白(RLSP)免疫的系列前瞻性研究,采用淋巴细胞转化试验。在就诊后2周内的首次检测中,56%的HBsAg阳性病例和63%的HBsAg阴性组的刺激指数升高。在疾病过程中观察到刺激指数逐渐恢复到正常水平。然而,有1例患者在就诊6个月后刺激指数仍居高不下,肝脏活检显示为慢性活动性肝炎。当使用大分子肾蛋白组分作为抗原时,观察到结果在正常范围内:这进一步证明了RLSP制剂中存在一种器官特异性成分,免疫反应似乎针对该成分。这些发现表明,无论HBsAg状态如何,急性病毒性肝炎患者对RLSP存在共同且有时间限制的致敏反应。有人提出,在评估肝脏疾病中的免疫反应时,RLSP可能是人类LSP的一种有用替代物。